Lument Finance Trust, Inc. (NYSE:LFT) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET
Company Participants
Andrew Tsang - Investor Relations
James Flynn - Chief Executive Officer
James Briggs - Chief Financial Officer
James Henson - President
Zachary Halpern - Senior Director, Portfolio Management
Conference Call Participants
Stephen Laws - Raymond James
Steve Delaney - JMP Securities
Matthew Erdner - JonesTrading
Christopher Nolan - Ladenburg Thalmann
Operator
Good morning and thank you for joining the Lument Finance Trust Third Quarter 2023 Earnings Call. Today’s call is being recorded and will be made available via webcast on the company’s website. I would now like to turn the floor over to Andrew Tsang with Investor Relations at Lument Investment Management. Please go ahead.
Andrew Tsang
Thank you, and good morning, everyone. Thank you for joining our call to discuss Lument Finance Trust’s third quarter 2023 financial results. With me on the call today are James Flynn, CEO; James Briggs, CFO; and James Henson, President; and Zachary Halpern, Senior Director of Portfolio Management. Yesterday on Monday, November 13, we filed our 10-Q with the SEC and issued a press release to provide details on our third quarter results. We also provided a supplemental earnings presentation, which can be found on our website.
Before handing the call over to Jim Flynn, I’d like to remind everyone that certain statements made during the course of this call are not based on historical information and may constitute forward-looking statements within the meaning of Section 27A, The Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. When used in this conference call, words outlook, value indicate, believes, will, anticipates, expects, intends and other similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from those
- Read more current LFT analysis and news
- View all earnings call transcripts